HPS Pharmacies wish to advise that Orion is experiencing a supply interruption for Bisalax® as follows:
Bisalax® Enema
Bisacodyl 10mg/5mL
ARTG 27900
This supply interruption is expected to resolve by early November 2024.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. This product, Toilax®, is registered for use in Finland and all packaging is in Finnish and Swedish. However, the active ingredient and strength are recognisable in English.
The Finnish product is manufactured in the same facility as the Australian registered product and is identical for active ingredient and strength. The differences between the two products are shown in the table below.
| Bisalax® | Toilax® | |
| Product type | Australian registered | S19A |
| Labelled strength | 10mg/5mL | 2mg/mL |
| Pack size | 25 enema tubes | 50 enema tubes |
| Language | English | Finnish and Swedish |
As the patient leaflet contained within the S19A alternative is not in English, patients can be referred to the Australian Consumer Medicines Information (CMI) brochure.
Retain this notice in a prominent position, including in other related business units, until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Orion on (02) 8067 8704 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates